According to Fortune Business Insights, the global AI in bioinformatics market size was valued at USD 1.06 billion in 2025. The market is projected to grow from USD 1.22 billion in 2026 to USD 4.80 billion by 2034, exhibiting a CAGR of 18.63% during the forecast period. North America dominated the AI in bioinformatics market with a market share of 41.51% in 2025.
The AI in bioinformatics market is gaining momentum as artificial intelligence technologies are increasingly integrated into biological data analysis, drug discovery, genomic research, precision medicine, and other life science applications. The growing volume and complexity of biological datasets is encouraging researchers and organizations to adopt AI-driven tools for faster and more efficient interpretation.
Continue reading for more details:
https://www.fortunebusinessinsights.com/ai-in-bioinformatics-market-115851
The AI in bioinformatics market can be segmented based on component, technology, application, end user, and geography. Based on component, the market includes software and services. AI-enabled software assists researchers in processing, analyzing, and interpreting complex biological datasets, while services support implementation, integration, consulting, maintenance, and specialized analytical requirements. By technology, the market includes machine learning, deep learning, natural language processing, computer vision, and other AI technologies. Machine learning and deep learning are increasingly used for identifying patterns in genomic and molecular datasets, while natural language processing can support the extraction of information from scientific literature and biological databases. Based on application, the AI in bioinformatics market covers drug discovery and development, genomics, proteomics, metabolomics, precision medicine, clinical research, and other applications. Drug discovery is an important application because AI can assist researchers in identifying potential drug candidates and analyzing molecular interactions. Genomics is also gaining attention as AI can support sequence analysis, variant interpretation, and biological data processing. Based on end user, the market includes pharmaceutical and biotechnology companies, academic and research institutions, healthcare organizations, and other users.
The AI in bioinformatics market is experiencing strong development as life science organizations increasingly rely on computational technologies to process complex biological information. The rapid expansion of genomic, proteomic, molecular, and clinical datasets has created a growing need for advanced analytical systems capable of identifying meaningful patterns and relationships. Artificial intelligence can help researchers automate repetitive analytical processes, improve data interpretation, and support decision-making throughout research workflows. Drug discovery is an important growth area because pharmaceutical and biotechnology companies are exploring AI-powered approaches to identify potential therapeutic candidates, evaluate molecular characteristics, and optimize research processes. AI is also supporting target identification, molecular modeling, biomarker discovery, and other activities associated with pharmaceutical research. The growing adoption of precision medicine is further creating opportunities for AI in bioinformatics. Researchers and healthcare organizations are increasingly interested in analyzing biological information to support more personalized approaches to disease understanding and treatment selection. Advances in machine learning and deep learning are improving the ability of computational systems to process large and complex biological datasets. Natural language processing is also creating opportunities by enabling the analysis of scientific publications, clinical information, and other text-based resources. The increasing availability of cloud computing infrastructure is supporting AI adoption by providing scalable computational capabilities for research organizations and businesses. Collaboration between technology companies, pharmaceutical firms, biotechnology companies, universities, and research institutions is also encouraging innovation. These collaborations can accelerate the development of AI-powered bioinformatics platforms and expand their application across different areas of life science research. As organizations continue to prioritize data-driven research and technological innovation, the AI in bioinformatics market is expected to benefit from increasing adoption across pharmaceutical, biotechnology, healthcare, and academic environments.